Plastic & reconstructive surgery recovery: BPC-157 and TB-500.

What actually limits surgical recovery

Every surgical incision heals in the same four phases. Hemostasis seals the wound within hours. Inflammation clears debris over the first several days — that is the swelling, warmth, and bruising you see. Proliferation, from roughly day four through week three, is when fibroblasts lay down collagen, new capillaries form, and the skin edges close. Remodeling then continues for months to as long as two years, reorganizing early collagen into stronger, better-aligned tissue. Your final scar is decided in that last phase, long after you feel recovered.

In plastic and reconstructive surgery specifically, recovery is usually limited by a predictable list: prolonged swelling and bruising from disrupted lymphatics, seroma in surgically created dead space, fibrosis or capsular contracture from disorganized collagen, widened or hypertrophic scars from abnormal remodeling, slow incision healing under tension, and — most consequentially — inadequate blood supply to flaps or repositioned tissue, which is the leading cause of partial flap loss and fat necrosis.

That list is why recovery peptides draw so much interest: perfusion, inflammation, and collagen organization are exactly the variables BPC-157 and TB-500 have been studied against in animal models. It is also why the honest framing on this page matters — the outcomes people most want improved are the ones with the least human evidence behind them.

How BPC-157 and TB-500 are thought to work

BPC-157 is a synthetic 15-amino-acid peptide based on a sequence from a protective protein found in human gastric juice. In rodent research it has been shown to modulate VEGF receptor signaling — the pathway that drives new blood vessel formation — and to accelerate healing in tendon, muscle, and skin injury models, including alkali burns, where it promoted keratinocyte and fibroblast migration alongside angiogenesis. Histology in those studies described more organized collagen and better granulation tissue than in untreated controls.

TB-500 is a synthetic fragment of thymosin beta-4, a protein your own platelets release at the site of any injury. Its best-characterized biochemistry is binding actin, the structural protein that governs cell movement — which is the mechanistic basis for its documented promotion of cell migration. Reviews of preclinical models and early investigational human work with pharmaceutical thymosin beta-4 have described accelerated dermal wound healing through keratinocyte migration, angiogenesis, and reduced inflammatory infiltration.

The two are stacked because the proposed mechanisms are complementary rather than duplicative: better blood supply and cytoprotection from one, faster cell migration and lower inflammation from the other. That combined rationale is theoretical. No published study has tested BPC-157 and TB-500 together in a surgical wound or flap model, in animals or in humans.

Researched benefits

This is a preclinical evidence base. The angiogenesis, wound healing, flap survival, and collagen findings come from rodent and in vitro studies, not human surgical patients. There are no completed, published randomized controlled trials of BPC-157 or TB-500 for post-surgical or cosmetic wound healing. Neither peptide is FDA-approved, BPC-157 has been flagged by the FDA among bulk substances raising compounding safety questions, and their regulatory status remains under active federal review. Nothing here should be read as a promise about your swelling, your scar, or your result.

How recovery peptide is dosed

There is no validated human dosing protocol for either peptide around surgery. Protocols used in clinical practice commonly run BPC-157 at a few hundred micrograms daily, sometimes split into two doses, with TB-500 dosed in the low milligram range once or twice weekly during an initial phase of four to six weeks, then reassessed or reduced.

Timing is where clinical opinion diverges most. Some practitioners begin a week or two before surgery to prime tissue and continue for several weeks afterward through the proliferative phase. Others deliberately wait until incisions are stable, several days to a week post-operatively, to avoid any theoretical interference with early clot formation and flap perfusion. No trial has established a safe or optimal window relative to surgery. Your physician makes that call in coordination with your surgeon — not from a protocol you found online.

Both are prescribed exclusively as subcutaneous injections compounded by our licensed 503(A) pharmacy partner.

• Injectable (subcutaneous)

  Injected subcutaneously into fatty tissue — usually the abdomen or thigh, away from surgical sites and incisions unless your clinician directs otherwise. Most clients self-administer at home after brief instruction; the needle is very small and the injection takes under a minute.

At Origin Wellness, dosing is never self-directed. Your protocol is written by a licensed physician after reviewing your assessment, and it is adjusted at follow-up based on your response. Read more about how that review works on our approach page.

Safety, side effects, and who should avoid it

The single most important requirement on this page: your operating surgeon must know about and approve any peptide protocol before your procedure. Your surgeon and anesthesia team hold the full picture of your surgical plan, tissue status, bleeding risk, and other medications. Because these peptides have not been characterized in humans during the perioperative window, their potential effects on hemostasis, microvascular anastomosis healing, and flap perfusion are unknown rather than reassuringly benign. If your surgeon says no, the answer is no.

A second serious consideration applies to anyone with a cancer history — including patients undergoing mastectomy reconstruction. BPC-157's proposed mechanism involves promoting new blood vessel growth, and pro-angiogenic signaling is mechanistically relevant to tumor biology. That risk has not been documented in humans, and it has not been ruled out either. It needs explicit discussion with your surgeon and oncology team.

Finally, sourcing. Products sold online as BPC-157 or TB-500 are typically unregulated research chemicals with no assurance of sterility, identity, or concentration — an infection risk entirely separate from any biological effect. Ours are compounded by a licensed 503(A) pharmacy under sterile conditions after physician review.

• • Disclose your protocol to your operating surgeon and anesthesia team before surgery, and follow their decision.
• • Disclose any active or historical cancer diagnosis, including breast cancer, before starting.
• • Never substitute a peptide for surgical aftercare. Compression garments, drains, activity restriction, wound care, nutrition, and follow-up visits are what actually protect your result.
• • Stop smoking and nicotine entirely — it impairs tissue perfusion more than any peptide could plausibly improve it.
• • Do not inject into or immediately around incisions, drains, or surgical sites unless your clinician specifically directs it.
• • Not appropriate during pregnancy or breastfeeding without explicit clinician approval.
• • Report any unusual swelling, drainage, fever, or wound changes to your surgeon immediately — those are surgical questions, not peptide questions.

How recovery peptide fits into a full protocol

Clients ask about these protocols most often around abdominoplasty, breast augmentation and reconstruction, rhinoplasty, facelift, liposuction and body contouring, and gender-affirming surgery. The hope is consistent: less swelling and bruising, faster incision healing, less seroma and fibrosis, and a better scar. Those are reasonable hopes and they are also exactly what has not been tested in humans for these procedures, so we frame this as supportive adjunctive care with an uncertain magnitude of benefit.

The protocol suits clients who have surgeon clearance, who are already committed to the aftercare fundamentals, and who want physician-supervised sourcing rather than a vial from an unregulated seller. Many pair recovery peptides with a glutathione protocol for antioxidant support during healing, or with sermorelin for recovery and tissue repair once they are further out from surgery.

Start a surgery recovery protocol

Get your operating surgeon's clearance first, then complete your free health assessment. A licensed physician reviews your procedure, timing, medications, and history before prescribing anything.

Frequently asked questions